Health Policy
-
September 10, 2025
Study reveals new evidence, cost savings for common treatments for opioid use disorder in mothers and infants
Researchers found that while established medications for opioid use disorder in mothers are both superior and cost saving compared to alternative treatment pathways, buprenorphine produced the greatest health gains and cost savings for mothers and infants. -
February 25, 2025
Metro Nashville Public Schools’ culture of wellness bolsters employee health, cuts costs
The MNPS Certificated Employee Health Plan covers 6,500 in collaboration with Vanderbilt Health active teachers plus 11,500 retirees and dependents. -
July 22, 2024
Opioid treatment can avoid foster care placement: study
If women are given medications to treat opioid use disorder during their pregnancy they are significantly more likely to retain custody of their newborns after delivery -
June 18, 2024
Study tallies reports of unprofessional behavior among physicians
Reports from 193 hospitals were analyzed. It turns out that surgeons draw the most complaints. -
May 16, 2024
Clinician accountability program from VUMC associated with large savings
A program run by Vanderbilt University Medical Center that provides peer feedback to high-risk clinicians was associated with a significant decrease in malpractice claims costs at a large orthopaedic surgery practice, according to a recent study. -
March 19, 2024
Over 40% of Tennessee Families With Children Say They Are Food Insecure; 70% Have Changed Spending on Food
This year’s Vanderbilt Child Health Poll shows that over 40% of Tennessee families report they are food insecure ― a similar proportion from last year. Most families (71%) say they have continued to change food spending habits due to high prices. -
March 15, 2024
Emerging Infections Program extends, expands disease surveillance research with new grant from the CDC
The Tennessee Emerging Infections Program has been awarded a new five-year grant from the Centers for Disease Control and Prevention to continue infectious disease surveillance research that has been conducted since 1999, and has expanded to include COVID, Mpox and HPV surveillance into oropharyngeal cancers.